Skip to content

In the BioHarmony Drug Report Database

Lonoctocog alfa

Afstyla (lonoctocog alfa) is an unknown pharmaceutical. Lonoctocog alfa was first approved as Afstyla on 2017-01-04. It is used to treat factor VII deficiency, hemophilia a, hemorrhage, and von willebrand diseases in the USA. It has been approved in Europe to treat hemophilia a.
Trade Name Afstyla
Common Name Lonoctocog alfa
Indication factor vii deficiency, hemophilia a, hemorrhage, von willebrand diseases
Drug Class
Lonoctocog alfa
Get full access now